Saturday, May 10, 2025 10:10:06 AM
And here's the 'official' spreadsheet link on the above page (hopefully, it works): https://www.england.nhs.uk/wp-content/uploads/2017/04/nhs-england-high-cost-drugs-list-2025-2026-version-20.0.xlsx
But for the record (and I am only saying this again because I want to verify that I am understanding this correctly and not missing something.):
The following are my words except when indicated by quotes. I used this formatting feature to make it easier to read:
1. The NHS (our equivalent to our FDA) added Murcidencel to the High-Cost Drug List. THIS IS APPROVAL!!!
2. On the NHS High-Cost Drug list, regarding Murcidencel (i.e. DCVax-L), it directly states "MEDICINES NOT REIMBURSED THROUGH NATIONAL PRICES AND COMMISSIONED BY NHS ENGLAND/CDF/IMF".
2a. The verbiage, "MEDICINES NOT REIMBURSED THROUGH NATIONAL PRICES", means these medicines are not covered under the standard national pricing framework (which typically applies to routinely commissioned treatments funded centrally by NHS England/NICE).
2b. The verbiage, "AND COMMISSIONED BY NHS ENGLAND/CDF/IMF", means that while Murcidencel is approved for treatment of “Cancer” (not just glioblastoma-- see the 'INDICATION" column), they require alternative government funding mechanisms via NHS England, Cancer Drugs Fund (CDF) and Innovative Medicines Fund (IMF) on a case-by-case basis (i.e. “AS PER IFR APPROVAL”).
3. THIS IS A BIG &$^$^$ DEAL, IS IT NOT?
"Against stupidity, we are defenseless"-- Dietrich Bonhoeffer, an anti-Nazi German Theologian, executed in the final days of the Nazi regime.
